logo-loader
RNS
Clinigen Group PLC

Clinigen Group plc - Director/PDMR Shareholding

RNS Number : 3979D
Clinigen Group plc
28 October 2020
 

28 October 2020

 

Purchase of shares and PDMR notification

Clinigen Group plc (AIM: CLIN, "Clinigen" or the "Company"), announces that, on 27 October 2020, four Board directors and a person closely associated with a director acquired ordinary shares in the Group as follows:

Name, title

Number of shares purchased

Per Share Price

purchased

Aggregated total

Peter Allen, Chairman

5,000

609.00p

£30,450

Ian Nicholson, NED

2,000

603.52p

£12,070

Anne Hyland, NED

7,716

606.98p

£46,835

Alan Boyd, NED

7,000

607.24p

£42,507

Catherine Nicholson

1,000

600.97p

£6,010

 

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

 

-Ends-

 

Contact Details

 

Clinigen Group plc

Tel: +44 (0) 1283 495 010

Shaun Chilton, Group Chief Executive Officer

Nick Keher, Group Chief Financial Officer




J.P.Morgan Cazenove - Nominated Adviser & Joint Broker

Tel: +44 (0)20 7742 4000

James Mitford / Hemant Kapoor

 



RBC Capital Markets - Joint Broker

Tel: +44 (0)20 7653 4000

Marcus Jackson / Elliot Thomas




Instinctif Partners

Melanie Toyne Sewell / Phillip Marriage / Nathan Billis

Tel:  +44 (0)20 7457 2020

Email: clinigen@instinctif.com

 

Notes to Editors

About Clinigen Group

Clinigen Group plc (AIM: CLIN) is a global pharmaceutical and services company with a unique combination of businesses focused on providing ethical access to medicines. Its mission is to deliver the right medicine to the right patient at the right time through three areas of global medicine supply; clinical trial, unlicensed and licensed medicines. The Group has sites in North America, Europe, Africa and the Asia Pacific.

 

Clinigen now has over 1,150 employees across five continents in 14 countries, with supply and distribution hubs and operational centres of excellence in key long-term growth regions. The Group works with 21 of the top 25 pharmaceutical companies; interacting with over 18,000 registered users across over 115 countries, shipping approximately 6.5 million units in the year.

 

For more information on Clinigen, please visit www.clinigengroup.com

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Peter Allen

2

Reason for the notification

a)

Position/status

Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Clinigen Group plc

b)

Legal Entity Identifier

213800OBIKGI2JYYS227

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.1 pence each

 

 

 

GB00B89J2419

b)

Nature of the transaction

Purchase of shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

609.00p per share

5,000 shares

 

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

 

5,000 shares

609.00p

£30,450

f)

Date of the transaction

27 October 2020

g)

Place of the transaction

London Stock Exchange, AIM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Ian Nicholson

2

Reason for the notification

a)

Position/status

Non Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Clinigen Group plc

b)

Legal Entity Identifier

213800OBIKGI2JYYS227

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.1 pence each

 

 

 

GB00B89J2419

b)

Nature of the transaction

Purchase of shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

603.52p per share

2,000 shares

 

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

 

2,000 shares

603.52p

£12,070

 

f)

Date of the transaction

27 October 2020

g)

Place of the transaction

London Stock Exchange, AIM

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Catherine Nicholson

2

Reason for the notification

a)

Position/status

Person closely associated with Ian Nicholson,
Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Clinigen Group plc

b)

Legal Entity Identifier

213800OBIKGI2JYYS227

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.1 pence each

 

 

 

GB00B89J2419

b)

Nature of the transaction

Purchase of shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

600.97p per share

1,000 shares

 

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

 

1,000 shares

600.97p

£6,010

 

f)

Date of the transaction

27 October 2020

g)

Place of the transaction

London Stock Exchange, AIM

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Anne Hyland

2

Reason for the notification

a)

Position/status

Non Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Clinigen Group plc

b)

Legal Entity Identifier

213800OBIKGI2JYYS227

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.1 pence each

 

 

 

GB00B89J2419

b)

Nature of the transaction

Purchase of shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

607.00p per share

606.97p per share

3,858 shares

3,858 shares

 

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

 

7,716 shares

606.98p

£46,835

 

f)

Date of the transaction

27 October 2020

g)

Place of the transaction

London Stock Exchange, AIM

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Alan Boyd

2

Reason for the notification

a)

Position/status

Non Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Clinigen Group plc

b)

Legal Entity Identifier

213800OBIKGI2JYYS227

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.1 pence each

 

 

 

GB00B89J2419

b)

Nature of the transaction

Purchase of shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

607.24p per share

7,000 shares

 

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

 

7,000 shares

607.24p

£42,507

 

f)

Date of the transaction

27 October 2020

g)

Place of the transaction

London Stock Exchange, AIM

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFITIALDFII
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

5 min read